A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV
A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV
Active, not recruiting · NCT06919016 · Registry updated 2025-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV | HIV-1-infection | Active, not recruiting | Phase 1 | 2025-12-16 | NCT06919016 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Department of Health and Human Services | 32 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
| National Institutes of Health (NIH) | 667 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital (Site ID: 30007) | Boston | United States | 1 |
| Columbia P&S CRS (Site ID: 30329) | New York | United States | 2 |
| Seattle Vaccine and Prevention CRS (Site ID: 30331) | Seattle | United States | 1 |
| The Hope Clinic of the Emory Vaccine Center CRS (Site ID: 31440) | Decatur | United States | 1 |
| University of Alabama Medical Center (Site ID: 31788) | Birmingham | United States | 1 |
| University of Pittsburgh (Site ID: 1001) | Pittsburgh | United States | 3 |
| University of Rochester Medical Center (Site ID: 31467) | Rochester | United States | 1 |
| Vanderbilt University Medical Center (Site ID: 30352) | Nashville | United States | 1 |